Bromantane 25 mg – 60 capsules

Original price was: 64,99 €.Current price is: 55,24 €.

Find out what benefits peptides have

Discover how peptides can boost recovery, improve skin health, increase energy and support overall performance. Explained simply and clearly in this short video.

Research Compound · Capsules

Bromantane 25 mg – 60 Capsules

Research-grade compound supplied as 60 pre-portioned capsules, each containing 25 mg bromantane (Ladasten). An adamantane-derivative compound studied in controlled experimental models of dopaminergic transmission, neuroplasticity and synaptogenesis, stress/fatigue response pathways, and mitochondrial bioenergetics.

Research Use Only
This product is intended strictly for laboratory and scientific investigation. Not for human consumption, therapeutic use, or veterinary application.

Specifications

Purity
≥99% (HPLC, third-party tested, CoA on file)
Form
Research capsules
Content per Capsule
25 mg bromantane
Total per Bottle
60 capsules (1.5 g total)
Packaging
Sealed bottle with tamper-evident closure
Storage
Store at room temperature, dry, protected from light
Molecular Formula
C₁₆H₂₀BrN
Molecular Weight
≈ 306.25 g/mol
IUPAC Name
N-(4-bromophenyl)adamantan-2-amine
CAS Number
87913-26-6

Format

Supplied as pre-portioned research capsules — no reconstitution or weighing is required, supporting consistent dosing accuracy in controlled experimental workflows. Keep the bottle sealed and stored at room temperature, dry and protected from light.

Research Overview

Bromantane (Ladasten) is an adamantane-derivative compound developed in Russia in the 1980s. Mechanistically, it is distinguished from classical psychostimulants by acting on dopamine biosynthesis rather than monoamine release — upregulating tyrosine hydroxylase and aromatic L-amino acid decarboxylase expression while modulating dopamine transporter activity. It is characterised in the literature as an actoprotector, and in controlled experimental settings it is used as a tool compound in dopaminergic signaling, neuroplasticity and stress/fatigue-response research. No therapeutic or clinical claims are made or implied.

Primary Research Areas

Dopaminergic Signaling
Studied for regulation of tyrosine hydroxylase and dopamine transporter activity, alongside downstream transcriptional programs.
Neuroplasticity & Synaptogenesis
Investigated using spine-density and synaptic-protein markers in neuronal assay systems.
Stress & Fatigue Response Models
Applied as a reference actoprotector compound with behavioral and biochemical endpoints in controlled paradigms.
Mitochondrial Bioenergetics
Examined through cellular respiration and membrane-potential readouts under controlled conditions.

RELATED PRODUCTS